PENETANGUISHENE, ON, Jan. 22, 2018 — Champlain Farma Corporation has recently applied under the Access to Cannabis for Medical Purposes Regulations (ACMPR). Phase 1 of the business plan includes a facility retrofit to provide a total of 30,000 sq. ft., indoor, state of the art, medical cannabis production and processing. Champlain Farma will be cultivating and producing cannabis extracts at its facility located in the industrial park of Penetanguishene.

Upon Champlain Farma receiving regulatory approval to produce its forecasted capacity of 12,600 kgs of fresh cannabis, Champlain Farma will quickly become a leader in the industry with a prime focus of producing a safe, standardized and specific extracted cannabis oil. A focus of up to five different strains of standardized medical grade cannabis with active concentrations of THC and/or CBD.

About Champlain Farma

Since 2014, the principals of Champlain Farma having been caring for patients considering cannabis as a treatment option through Simcoe Holistic Health, in Barrie, ON. Overtime, the “life-changing” feedback received from patient’s treatment has been overwhelming and something we are proud to be a part of. As the industry grows patients are concerned with sustainable access to their medical cannabis. Focused on quality medical care, we knew we had a role to play and began Champlain Farma Corporation, driven on producing sustainable cannabis extracts.

For further information: please visit our website or contact Doug Rawson, President & CEO at 705-230-6457 (OILS); or Mark Tremblay, VP Facilities & Operations; or Dr. Mark Churman, Medical Director.